Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells

Abstract The effects of evodiamine (EVO) on oral squamous cell carcinoma (OSCC) are not yet understood. Based on our earlier findings, we hypothesized that evodiamine may affect OSCC cell proliferation and glutamate metabolism by modulating the expression of EPRS (glutamyl‐prolyl‐tRNA synthetase 1)....

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Li‐Qi Lin, Si‐Yi Lv, Hao‐Zhe Ren, Rong‐Rong Li, Lin Li, Yun‐Qing Pang, Jing Wang
বিন্যাস: প্রবন্ধ
ভাষা:English
প্রকাশিত: Wiley 2024-04-01
মালা:Kaohsiung Journal of Medical Sciences
বিষয়গুলি:
অনলাইন ব্যবহার করুন:https://doi.org/10.1002/kjm2.12803
_version_ 1827289684659666944
author Li‐Qi Lin
Si‐Yi Lv
Hao‐Zhe Ren
Rong‐Rong Li
Lin Li
Yun‐Qing Pang
Jing Wang
author_facet Li‐Qi Lin
Si‐Yi Lv
Hao‐Zhe Ren
Rong‐Rong Li
Lin Li
Yun‐Qing Pang
Jing Wang
author_sort Li‐Qi Lin
collection DOAJ
description Abstract The effects of evodiamine (EVO) on oral squamous cell carcinoma (OSCC) are not yet understood. Based on our earlier findings, we hypothesized that evodiamine may affect OSCC cell proliferation and glutamate metabolism by modulating the expression of EPRS (glutamyl‐prolyl‐tRNA synthetase 1). From GEPIA, we obtained EPRS expression data in patients with OSCC as well as survival prognosis data. An animal model using Cal27 cells in BALB/c nude mice was established. The expression of EPRS was assessed by immunofluorescence, Western blotting, and quantitative PCR. Glutamate measurements were performed to evaluate the impact of evodiamine on glutamate metabolism of Cal27 and SAS tumor cells. transient transfection techniques were used to knock down and modulate EPRS in these cells. EPRS is expressed at higher levels in OSCC than in normal tissues, and it predicts poor prognosis in patients. In a nude mouse xenograft model, evodiamine inhibited tumor growth and the expression of EPRS. Evodiamine impacted cell proliferation, glutamine metabolism, and EPRS expression on Cal27 and SAS cell lines. In EPRS knockdown cell lines, both cell proliferation and glutamine metabolism are suppressed. EPRS's overexpression partially restores evodiamine's inhibitory effects on cell proliferation and glutamine metabolism. This study provides crucial experimental evidence supporting the potential therapeutic application of evodiamine in treating OSCC. Evodiamine exhibits promising anti‐tumor effects by targeting EPRS to regulate glutamate metabolism.
first_indexed 2024-04-24T11:54:17Z
format Article
id doaj.art-43f14f31f876482ea425f7d4bc504af7
institution Directory Open Access Journal
issn 1607-551X
2410-8650
language English
last_indexed 2024-04-24T11:54:17Z
publishDate 2024-04-01
publisher Wiley
record_format Article
series Kaohsiung Journal of Medical Sciences
spelling doaj.art-43f14f31f876482ea425f7d4bc504af72024-04-09T05:56:38ZengWileyKaohsiung Journal of Medical Sciences1607-551X2410-86502024-04-0140434835910.1002/kjm2.12803Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cellsLi‐Qi Lin0Si‐Yi Lv1Hao‐Zhe Ren2Rong‐Rong Li3Lin Li4Yun‐Qing Pang5Jing Wang6School/Hospital of Stomatology Lanzhou University Lanzhou Gansu ChinaSchool/Hospital of Stomatology Lanzhou University Lanzhou Gansu ChinaSchool/Hospital of Stomatology Lanzhou University Lanzhou Gansu ChinaSchool/Hospital of Stomatology Lanzhou University Lanzhou Gansu ChinaSchool/Hospital of Stomatology Lanzhou University Lanzhou Gansu ChinaSchool/Hospital of Stomatology Lanzhou University Lanzhou Gansu ChinaSchool/Hospital of Stomatology Lanzhou University Lanzhou Gansu ChinaAbstract The effects of evodiamine (EVO) on oral squamous cell carcinoma (OSCC) are not yet understood. Based on our earlier findings, we hypothesized that evodiamine may affect OSCC cell proliferation and glutamate metabolism by modulating the expression of EPRS (glutamyl‐prolyl‐tRNA synthetase 1). From GEPIA, we obtained EPRS expression data in patients with OSCC as well as survival prognosis data. An animal model using Cal27 cells in BALB/c nude mice was established. The expression of EPRS was assessed by immunofluorescence, Western blotting, and quantitative PCR. Glutamate measurements were performed to evaluate the impact of evodiamine on glutamate metabolism of Cal27 and SAS tumor cells. transient transfection techniques were used to knock down and modulate EPRS in these cells. EPRS is expressed at higher levels in OSCC than in normal tissues, and it predicts poor prognosis in patients. In a nude mouse xenograft model, evodiamine inhibited tumor growth and the expression of EPRS. Evodiamine impacted cell proliferation, glutamine metabolism, and EPRS expression on Cal27 and SAS cell lines. In EPRS knockdown cell lines, both cell proliferation and glutamine metabolism are suppressed. EPRS's overexpression partially restores evodiamine's inhibitory effects on cell proliferation and glutamine metabolism. This study provides crucial experimental evidence supporting the potential therapeutic application of evodiamine in treating OSCC. Evodiamine exhibits promising anti‐tumor effects by targeting EPRS to regulate glutamate metabolism.https://doi.org/10.1002/kjm2.12803evodiamineglutamate metabolismglutamyl‐prolyl‐tRNA synthetase 1 (EPRS)oral squamous cell carcinomaproliferation
spellingShingle Li‐Qi Lin
Si‐Yi Lv
Hao‐Zhe Ren
Rong‐Rong Li
Lin Li
Yun‐Qing Pang
Jing Wang
Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells
Kaohsiung Journal of Medical Sciences
evodiamine
glutamate metabolism
glutamyl‐prolyl‐tRNA synthetase 1 (EPRS)
oral squamous cell carcinoma
proliferation
title Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells
title_full Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells
title_fullStr Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells
title_full_unstemmed Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells
title_short Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells
title_sort evodiamine inhibits eprs expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells
topic evodiamine
glutamate metabolism
glutamyl‐prolyl‐tRNA synthetase 1 (EPRS)
oral squamous cell carcinoma
proliferation
url https://doi.org/10.1002/kjm2.12803
work_keys_str_mv AT liqilin evodiamineinhibitseprsexpressiontoregulateglutamatemetabolismandproliferationoforalsquamouscellcarcinomacells
AT siyilv evodiamineinhibitseprsexpressiontoregulateglutamatemetabolismandproliferationoforalsquamouscellcarcinomacells
AT haozheren evodiamineinhibitseprsexpressiontoregulateglutamatemetabolismandproliferationoforalsquamouscellcarcinomacells
AT rongrongli evodiamineinhibitseprsexpressiontoregulateglutamatemetabolismandproliferationoforalsquamouscellcarcinomacells
AT linli evodiamineinhibitseprsexpressiontoregulateglutamatemetabolismandproliferationoforalsquamouscellcarcinomacells
AT yunqingpang evodiamineinhibitseprsexpressiontoregulateglutamatemetabolismandproliferationoforalsquamouscellcarcinomacells
AT jingwang evodiamineinhibitseprsexpressiontoregulateglutamatemetabolismandproliferationoforalsquamouscellcarcinomacells